Alivus Life Sciences Ltd vs Panjon Ltd Stock Comparison
Alivus Life Sciences Ltd vs Panjon Ltd Stock Comparison
Last Updated on: May 05, 2026
Key Highlights
The Latest Trading Price of Alivus Life Sciences Ltd is ₹ 1046 as of 13 Apr 15:30
. The P/E Ratio of Alivus Life Sciences Ltd changed from 13.4 on March 2022 to 27.2 on March 2025 . This represents a CAGR of 19.36% over 4 yearsThe P/E Ratio of Panjon Ltd changed from 22.4 on March 2023 to 97.8 on March 2025 . This represents a CAGR of 63.44% over 3 years The Market Cap of Alivus Life Sciences Ltd changed from ₹ 5624 crore on March 2022 to ₹ 13229 crore on March 2025 . This represents a CAGR of 23.84% over 4 yearsThe Market Cap of Panjon Ltd changed from ₹ 27.28 crore on March 2022 to ₹ 38.6 crore on March 2025 . This represents a CAGR of 9.07% over 4 years The revenue of Alivus Life Sciences Ltd for the Dec '25 is ₹ 686.82 crore as compare to the Sep '25 revenue of ₹ 602.7 crore. This represent the growth of 13.96% The revenue of Panjon Ltd for the Dec '25 is ₹ 14.18 crore as compare to the Sep '25 revenue of ₹ 14.99 crore. This represent the decline of -5.4% The ebitda of Alivus Life Sciences Ltd for the Dec '25 is ₹ 219.54 crore as compare to the Sep '25 ebitda of ₹ 193.89 crore. This represent the growth of 13.23% The ebitda of Panjon Ltd for the Dec '25 is ₹ 0.33 crore as compare to the Sep '25 ebitda of ₹ 0.31 crore. This represent the growth of 6.45% The net profit of Alivus Life Sciences Ltd changed from ₹ 111.48 crore to ₹ 150.26 crore over 7 quarters. This represents a CAGR of 18.60%
The net profit of Panjon Ltd changed from ₹ 0.03 crore to ₹ 0.22 crore over 7 quarters. This represents a CAGR of 212.22%
The Dividend Payout of Alivus Life Sciences Ltd changed from 61.46 % on March 2022 to 12.62 % on March 2025 . This represents a CAGR of -32.68% over 4 yearsThe Dividend Payout of Panjon Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .
About Alivus Life Sciences Ltd
Alivus Life Sciences Limited was initially established as 'Zorg Laboratories Private Limited', on June 23, 2011 and was granted the Certificate of Incorporation by the Registrar of Companies, Maharashtra in Pune.
Subsequently, the Company was acquired by Glenmark Pharmaceuticals Limited through a Share Purchase Agreement dated 04 July 2018 and the name of the Company was changed to Glenmark Life Sciences Private Limited' and a fresh Certificate of Incorporation dated 28 August 2018 was issued by the RoC. The name of the Company has now changed to 'Alivus Life Sciences Limited' on January 20, 2025.
Nirma Limited is a Subsidiary of the Company.
The Company is engaged in the business of development, manufacture and marketing of Active Pharmaceutical Ingredients(APIs).
In 2001, Glenmark Pharmaceuticals established its API business.
About Panjon Ltd
Incorporated in Dec.'83 Panjon Limited became public in 1992.
The Company was promoted by Nagin Kothari and Manoj Kothari.
The Company is a leading FMCG company.
It has marked its presence with significant achievements and today commands a remarkable market status.
Panjon today has renowned products like PANJON Tablet , PANJON Balm , PANJON Inhaler, PANJON cough drops, Swad Digestive Drops, Swad Chatpati Drops, Swad Chyawanpra Candy,Percy Masala Candy, Panjon Swad PACHAK range : Shahi Anardana, Special Jeera Goli, Hing Peda, Albela Aam, Khatta Meetha Khajoor, Chatpata Amla, Chulbuli Imli and many more.
The Company manufactures and markets consumer and pharmaceutical products which are low priced and within the reach of the common man.
FAQs for the comparison of Alivus Life Sciences Ltd and Panjon Ltd
Which company has a larger market capitalization, Alivus Life Sciences Ltd or Panjon Ltd?
Market cap of Alivus Life Sciences Ltd is 13,106 Cr while Market cap of Panjon Ltd is 40 Cr
What are the key factors driving the stock performance of Alivus Life Sciences Ltd and Panjon Ltd?
The stock performance of Alivus Life Sciences Ltd and Panjon Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Alivus Life Sciences Ltd and Panjon Ltd?
As of May 5, 2026, the Alivus Life Sciences Ltd stock price is INR ₹1067.85. On the other hand, Panjon Ltd stock price is INR ₹23.61.
How do dividend payouts of Alivus Life Sciences Ltd and Panjon Ltd compare?
To compare the dividend payouts of Alivus Life Sciences Ltd and Panjon Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.